NCT01546324View on ClinicalTrials.gov

Collection of Maternal Blood Samples for Development of Non-invasive Prenatal Diagnostic Testing

CompletedOBSERVATIONAL
Enrollment

16

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

August 31, 2013

Conditions
Pregnancy Following IVF With PGS/PGD
Interventions
PROCEDURE

Blood draw

Maternal blood draw at approximately 8-17 weeks gestation.

Trial Locations (1)

94063

Natera, Inc, Redwood City

Sponsors

Lead Sponsor

Natera, Inc.
All Listed Sponsors
lead

Natera, Inc.

INDUSTRY

NCT01546324 - Collection of Maternal Blood Samples for Development of Non-invasive Prenatal Diagnostic Testing | Biotech Hunter | Biotech Hunter